Antibodies' long revenue stream spurs pharma acquisitions.
Mitchell
Peter
P
D000906:Antibodies / Q000191:economics* / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics* / Q000639:trends*; D006801:Humans; D014481:United States
D000906:Antibodies